Navigation Links
Adeona Reports Third Quarter 2011 Financial Results
Date:11/14/2011

ANN ARBOR, Mich., Nov. 14, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, today reported its third quarter 2011 financial results for the period ended September 30, 2011, as well as updates since the beginning of the third quarter.

Updates since the beginning of the third quarter include:

Drug Development Programs

Relapsing-Remitting Multiple Sclerosis (MS)

  • As of September 19, 2011, the 150th patient was enrolled in the clinical trial evaluating Trimesta™ (oral estriol) in women suffering from relapsing-remitting MS, per the original protocol.

  • The Lead Principal Investigator, Rhonda Voskuhl, M.D., Director, University of California, Los Angeles (UCLA) Multiple Sclerosis Program, Department of Neurology, is using grant funding to continue enrollment of an additional 10-20 patients at all 15 centers in the United States.

Cognitive Dysfunction in MS

  • On November 11, 2011, we announced that our drug candidate, Trimesta, will be utilized in a new randomized, double-blind, placebo-controlled Phase II clinical trial to evaluate its potential therapeutic effect on cognitive dysfunction in women suffering from MS, a major consequence of this disease.

  • We and the Skirball Foundation have pledged to equally support this clinical trial led by Dr. Voskuhl. The study, which focuses on cognition dysfunction in MS patients, also received financial support from the Sherak Family Fund, the Gustafson Fund, and the Diamont family.

Fibromyalgia

  • In May 2010, we announced a $17.5 million c
    '/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
2. Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting
3. Adeona Appoints Jeff Lucero Riley as Independent Chairman
4. Adeonas Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease is Hot Topic at 2011 California ALS Research Summit
5. Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
6. Adeona Appoints George A. Eby to Scientific Advisory Board
7. Adeona Reports Second Quarter 2011 Financial Results
8. Adeona to Host Second Quarter 2011 Investor Conference Call
9. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
10. Adeona Reports 1st Quarter 2011 Financial Results
11. Adeona to Host First Quarter 2011 Investor Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015 ... with Broda Technologies Co., Ltd., operating in both the ... the company,s proprietary IntelliGel ® supramolecular hydrogel technology ... development and other ophthalmic therapies. The Broda technology offers ... solution is a free-forming liquid and with low concentrations ...
(Date:7/2/2015)... July 2, 2015 ResMed Inc. (NYSE: RMD ... and fiscal year ended June 30, 2015 results on Thursday, ... close. A press release with ResMed,s results will be issued ... host a webcast to discuss operating results and future outlook. ... 1:30 p.m. US Pacific Time and the live webcast of ...
(Date:7/2/2015)... , July 2, 2015 Roche,s ... conspicuously high-growth market segment in hematology testing, according ... said that Roche,s recent unveiling of its Bloodhound digital ... cobas m 511 hematology analyzer – ... capture growth enjoyed by current leader CellaVision, but ...
Breaking Medicine Technology:Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
... March 19, 2012  There is a wide gender divide when ... adhere to their medications.  According to a new study, while ... likely to be prescribed drugs according to clinical guidelines and ... are prescribed.  The research was conducted by Medco Health Solutions, ...
... March 19, 2012 Ventana Medical Systems, Inc. ... Group, is now introducing a novel platform for ... technology.  Answering customers, challenges with their current process, ... offers walk-away automation, baking through staining including deparaffinization, ...
Cached Medicine Technology:More is Sometimes Less: Women are Prescribed a Greater Number of Medications Than Men but Take Less of the Drugs They Need 2More is Sometimes Less: Women are Prescribed a Greater Number of Medications Than Men but Take Less of the Drugs They Need 3More is Sometimes Less: Women are Prescribed a Greater Number of Medications Than Men but Take Less of the Drugs They Need 4Ventana Introduces the BenchMark Special Stains Platform 2Ventana Introduces the BenchMark Special Stains Platform 3
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top ... mesothelioma with even minimal asbestos exposure. Click here to read the complete story ... of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice ...
(Date:7/3/2015)... ... 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. ... Symposium . To be held from March 4th - 6th, the 2016 (a previous ... Galleria Dallas. , Designed to take participants from the basic training and fundamentals of ...
(Date:7/3/2015)... ... 2015 , ... B. E. Smith, the only full-service leadership ... national president recruitment for Regional Care, Inc. in Scottsbluff, Neb. One ... has recently placed more than 1,000 healthcare executives into organizations. , As ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. ... has been retained to lead a national chief nursing officer recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... took place on June 25, 2015 at 1:00pm. The Association welcomed speaker C. ... pertaining to injured bicyclists and practical points of investigating these types of cases. ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2
... limited pressure to achieve the ,thin and beautiful, ideal have ... study looking at five factors that may help young women ... of a society where discontent with appearance is common among ... of Arizona in the US, and colleagues is published online ...
... stimulating immune cells to more effectively battle cancerous tumors, ... effect, driving these intracellular fighters to exhaustion, a Mayo ... Journal of Clinical Investigation . The ... testing the treatment,s ability to ramp up the body,s ...
... News) -- Children who wake up at night and are allowed ... to be overweight than kids put back into their own bed, ... children aged 2 to 6 who had an increased risk of ... were overweight before becoming pregnant or their mothers were poor. ...
... News) -- Everyone knows teen behavior is highly influenced by their ... influence whether or not a teen drinks alcohol or uses drugs. ... their child,s drug or alcohol use, or worse, condone it, that ... study found. "Among friendship groups with ,good parents, there,s a ...
... HealthDay Reporter , TUESDAY, May 8 (HealthDay News) -- Women who ... to worry about gaining weight after the device is implanted, new ... aged 15 to 44 who were using two different types of ... About half of the women had a non-hormonal IUD containing copper ...
... A Wayne State University researcher believes a better ... one day help at-risk adolescents transition more quickly to ... To further that understanding, Tim Bogg, Ph.D., assistant ... and Sciences, has received a three-year, $731,000 grant from ...
Cached Medicine News:Health News:Self-worth needs to go beyond appearance 2Health News:Mayo Clinic: Exhaustion renders immune cells less effective in cancer treatment 2Health News:Study: Kids Who Sleep in Parents' Bed Less Likely to Be Overweight 2Health News:Friends' Parents Can Sway Teens' Odds for Drinking, Smoking 2Health News:IUD Use Tied to Modest Weight Loss 2Health News:IUD Use Tied to Modest Weight Loss 3Health News:WSU researches patterns of heavy alcohol use and life commitments in at-risk young adults 2Health News:WSU researches patterns of heavy alcohol use and life commitments in at-risk young adults 3
... provide excellent protection and ease of use. ... closer to an adhesive in molecular weight ... to maintain viscosity at high shear rates, ... for superb performance during capsulorhexis, phaco, IOL ...
151 channels cover the entire head with a high density, with provisions for the eyes and ears. Patients and subjects are examined in a comfortable seated position or laying down....
... The Magnes 1300 C is ideal for ... brain and other parts of the body. Often ... its possibilites, including magnetocardiography, gastrointestinal tract, fetal, spinal ... ,The 1300 C, with its 67 detector ...
... neutral pH bone putty that contains calcium-based ... for decades in orthopedic surgery. These materials ... source of bone to help the patient ... microstructure to enhance bone regeneration, provide optimal ...
Medicine Products: